4.3 Review

Clinical considerations on the use of concomitant therapy in the treatment of acne

期刊

JOURNAL OF DERMATOLOGICAL TREATMENT
卷 19, 期 4, 页码 199-209

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/09546630802132635

关键词

acne; acne vulgaris; benzoyl peroxide; concomitant therapy; lesion reduction; oral antibiotic; topical antibiotic; topical retinoid

向作者/读者索取更多资源

Acne is a disease that affects millions of people worldwide and requires prompt and effective management of both the physical and psychological sequelae that an individual may experience. The ultimate goal of treatment is to address as many of the pathogenic factors of acne as possible while minimizing side effects. Numerous therapeutic options are available; however, most current treatment options address only one or two of these factors. For this reason, combining single therapies has been the practice since the mid-1970s, beginning with the concomitant use of treatments such as topical vitamin A with systemic tetracyclines or topical benzoyl peroxide. As additional therapeutic options have emerged, dermatologists have also begun to utilize these treatments concomitantly based on their synergistic and multifactorial effects on the different pathogenic factors of acne. This review provides an update of recent advances and data regarding the concomitant use of various anti-acne agents.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Dermatology

Chronic itch in African Americans: an unmet need

Giuseppe Ingrasci, Nour El-Kashlan, Andrew Alexis, Gil Yosipovitch

Summary: Chronic pruritus disproportionately affects African Americans and racial differences in skin structure and function may contribute to the pathogenesis of itch in this population. Despite this, knowledge and management of pruritus in African Americans remain understudied and there is a significant unmet need in this area.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2022)

Letter Dermatology

The atopic dermatitis spectrum disorder. Recognizing the clinical heterogeneity in patients with atopic related skin conditions in order to improve therapeutic decision-making and outcomes: an expert panel consensus statement

Daniel C. Butler, Eric Simpson, Emma Guttman-Yassky, Lawrence F. Eichenfield, Alexandra K. Golant, John Y. M. Koo, April W. Armstrong, Andrew F. Alexis, Peter A. Lio, Justin W. Marson, Mark Lebwohl

JOURNAL OF DERMATOLOGICAL TREATMENT (2022)

Article Dermatology

Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review

Trisha Kaundinya, Uros Rakita, Armaan Guraya, Donna Maria Abboud, Emily Croce, Jacob P. Thyssen, Andrew Alexis, Jonathan Silverberg

Summary: The psychometric validity and reliability of widely used atopic dermatitis (AD) outcome measures across different races and ethnicities are unclear. This study systematically reviewed studies reporting psychometric properties of AD outcome measures and found a lack of consideration for race and ethnicity.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Review Dermatology

Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice

Valerie D. Callender, Hilary Baldwin, Fran E. Cook-Bolden, Andrew F. Alexis, Linda Stein Gold, Eric Guenin

Summary: Acne is a common cause of post-inflammatory hyperpigmentation (PIH), which can be more distressing to patients than the acne itself. Topical retinoids are effective in treating PIH, especially in patients with skin of color, and should be started early. Patients should manage their expectations during treatment, and combining retinoids with other treatments like chemical peels can help improve symptoms.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2022)

Letter Dermatology

Health-Related QOL Differs by Race/Ethnicity in North American Patients with Psoriasis: Results from PSOLAR

Junko Takeshita, Matthias Augustin, Elke M. G. J. de Jong, Kimberly Parnell Lafferty, Wayne Langholff, Richard G. Langley, Alan Menter, Andrew F. Alexis

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Dermatology

Misconceptions of photoprotection in skin of color

Susan C. Taylor, Andrew F. Alexis, April W. Armstrong, Zelma C. Chiesa Fuxench, Henry W. Lim

Summary: Terrestrial sunlight, which includes UV radiation, visible light, and infrared radiation, has deleterious effects on skin health, particularly in individuals with light skin tones and skin of color. Despite evolving recommendations from medical societies and the US Food and Drug Administration, misconceptions about skin damage related to sunlight and the benefits of photoprotection are still prevalent. Skin disorders and impaired skin health due to sun exposure negatively impact the quality of life in individuals with skin of color.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

Article Dermatology

Photoprotection for skin of all color: Consensus and clinical guidance from an expert panel

Darrell S. Rigel, Susan C. Taylor, Henry W. Lim, Andrew F. Alexis, April W. Armstrong, Zelma C. Chiesa Fuxench, Zoe D. Draelos, Iltefat H. Hamzavi

Summary: In recent decades, the negative effects of sun exposure have gained better recognition. While most attention has been on the effects of UVB light, there is increasing appreciation for the effects of longer wavelengths, such as UVA and visible light. Studies have shown that visible light can cause hyperpigmentation in individuals with dark skin and exacerbate pigmentary disorders. However, there are still gaps in understanding the need for photoprotection and guidance for clinicians.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

Article Dermatology

Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study

Andrew Alexis, Marjolein de Bruin-Weller, Stephan Weidinger, Weily Soong, Sebastien Barbarot, Ileana Ionita, Fan Zhang, Hernan Valdez, Claire Clibborn, Natalie Yin

Summary: This study investigated the effectiveness of abrocitinib in the treatment of atopic dermatitis (AD), finding that abrocitinib can rapidly and persistently improve symptoms of AD in different body regions, with particularly significant effects in difficult-to-treat areas such as the head and neck.

DERMATOLOGY AND THERAPY (2022)

Article Dermatology

Evolving Concepts in Psoriasis: Special Considerations for Patients With Skin of Color, Skin Barrier Dysfunction, and the Role of Adjunctive Skin Care

Andrew Alexis, Heather Woolery-Lloyd, Anneke Andriessen, John Koo, Amy McMichael, George Han

Summary: There is limited data on racial/ethnic variations, effects of skin care, and treatment implications for psoriasis patients with skin of color. Recognizing the impact of ethnicity on psoriasis can help reduce disparities in care and improve treatment outcomes.

JOURNAL OF DRUGS IN DERMATOLOGY (2022)

Article Allergy

Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic Dermatitis

Kristian Reich, Peter A. Lio, Robert Bissonnette, Andrew F. Alexis, Mark G. Lebwohl, Andrew E. Pink, Kenji Kabashima, Mark Boguniewicz, Roman J. Nowicki, Hernan Valdez, Fan Zhang, Marco DiBonaventura, Michael C. Cameron, Claire Clibborn

Summary: The study found that patients treated with abrocitinib and dupilumab had greater improvement in the symptoms and signs of moderate-to-severe atopic dermatitis compared to patients treated with placebo.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Article Dermatology

Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series

James Q. Del Rosso, Edward Lain, Jean Philippe York, Andrew Alexis

Summary: The clinical appearance and response to treatment of acne vulgaris may vary in people with skin of color compared with those with lighter skin types. This study demonstrates the favorable efficacy and safety of trifarotene 0.005% cream in treating facial and truncal acne in subjects with skin of color.

DERMATOLOGY AND THERAPY (2022)

Review Dermatology

The Impact of Global Health Disparities on Atopic Dermatitis in Displaced Populations: Narrowing the Health Equity Gap for Patients with Skin of Color

Sami Jelousi, Divya Sharma, Andrew Alexis, Jenny E. Murase

Summary: Atopic dermatitis is a common inflammatory skin disease that significantly affects the quality of life for those affected. Patients with skin of color have a greater disease burden compared to patients of European descent. There is a lack of research on the burden of atopic dermatitis experienced by refugees and migrants. Displaced individuals face unique risk factors that make them particularly vulnerable to the disease.

DERMATOLOGY AND THERAPY (2022)

Editorial Material Dermatology

Diversity, equity, and inclusion: The visionary future of JAAD

Andrew Alexis, J. Klint Peebles

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

Article Dermatology

Skin Barrier Deficiency in Rosacea: An Algorithm Integrating OTC Skincare Products Into Treatment Regimens

Hilary E. Baldwin, Andrew F. Alexis, Anneke Andriessen, Diane S. Berson, Julie Harper, Edward Lain, Shari Marchbein, Linda Stein Gold

Summary: This article presents an evidence-based clinical treatment and maintenance algorithm for the prevention, treatment, and management of rosacea. The algorithm includes foundational measures such as education, behavioral modifications, avoidance of triggers and skin irritants, preventative skincare, and sun avoidance and sunscreen use. The algorithm also provides guidance on assessing skin condition and grading of cutaneous rosacea during treatment and maintenance.

JOURNAL OF DRUGS IN DERMATOLOGY (2022)

Article Dermatology

Improving Rosacea Outcomes in Skin of Color Patients: A Review on the Nuances in the Treatment and the Use of Cleansers and Moisturizers

Andrew Alexis, Heather Woolery-Lloyd, Anneke Andriessen, Seemal Desai, George Han, David Rodriguez

Summary: This article explores the clinical presentation and treatment considerations of rosacea in skin of color populations and discusses the role of cleansers and moisturizers in managing rosacea. The findings suggest that rosacea is more common in individuals with darker skin, but the clinical features may be less noticeable, leading to underdiagnosis. Using moisturizers and sunscreen has been shown to improve rosacea symptoms.

JOURNAL OF DRUGS IN DERMATOLOGY (2022)

暂无数据